Nasdaq Stocks

Market indexes slogged forward most of the morning this Tuesday, finally looking to have gained some traction after the noon hour aheads of what was supposed to be renewed talks between House Speaker Nancy Pelosi and Treasury Secretary Steve Mnuchin this afternoon. Then, a Tweet

Enterprise Products Partners (EPD) closed at $16.39 in the latest trading session, marking a -0.36% move from the prior day. This change was narrower than the S&P 500's daily loss of 1.4%. Elsewhere, the Dow lost 1.34%, while the tech-heavy Nasdaq lost 1.57%.

Cloudflare (NET) closed at $42.23 in the latest trading session, marking a -1.47% move from the prior day. This change lagged the S&P 500's daily loss of 1.4%. Elsewhere, the Dow lost 1.34%, while the tech-heavy Nasdaq lost 1.57%.

Texas Instruments (TXN) closed the most recent trading day at $143.85, moving -0.16% from the previous trading session. This change was narrower than the S&P 500's daily loss of 1.4%. Meanwhile, the Dow lost 1.34%, and the Nasdaq, a tech-heavy index, lost 1.57%.

NextEra Energy (NEE) closed the most recent trading day at $290.28, moving +0.82% from the previous trading session. The stock outpaced the S&P 500's daily loss of 1.4%. Meanwhile, the Dow lost 1.34%, and the Nasdaq, a tech-heavy index, lost 1.57%.

B&G Foods (BGS) closed at $28.20 in the latest trading session, marking a -0.46% move from the prior day. This change was narrower than the S&P 500's 1.4% loss on the day. At the same time, the Dow lost 1.34%, and the tech-heavy Nasdaq lost 1.57%.

Chegg (CHGG) closed at $76.17 in the latest trading session, marking a +1.89% move from the prior day. The stock outpaced the S&P 500's daily loss of 1.4%. Elsewhere, the Dow lost 1.34%, while the tech-heavy Nasdaq lost 1.57%.

Teradyne (TER) closed the most recent trading day at $81.11, moving -0.15% from the previous trading session. This move was narrower than the S&P 500's daily loss of 1.4%. Elsewhere, the Dow lost 1.34%, while the tech-heavy Nasdaq lost 1.57%.

Zynga (ZNGA) closed the most recent trading day at $9.57, making no change from the previous trading session. This move was narrower than the S&P 500's daily loss of 1.4%. Elsewhere, the Dow lost 1.34%, while the tech-heavy Nasdaq lost 1.57%.

Starbucks (SBUX) closed the most recent trading day at $87.01, moving -1.65% from the previous trading session. This move lagged the S&P 500's daily loss of 1.4%. Meanwhile, the Dow lost 1.34%, and the Nasdaq, a tech-heavy index, lost 1.57%.

In the latest trading session, Spotify (SPOT) closed at $248.54, marking a -1.13% move from the previous day. This move was narrower than the S&P 500's daily loss of 1.4%. Meanwhile, the Dow lost 1.34%, and the Nasdaq, a tech-heavy index, lost 1.57%.

Paychex, Inc. PAYX reported better-than-expected first-quarter fiscal 2021 results.

Cigna Corp. CI seems well-poised for growth on the back of its vast and diversified business profile, a solid balance sheet and a strong operating performance.

Thanks to coronavirus-induced weak air-travel demand, Gol Linhas Aereas Inteligentes’ GOL traffic, measured in revenue passenger kilometers, plunged 60.6% year over year in September.

In the past week, United Airlines UAL announced its decision to re-start nonstop services to China later this month through flights connecting San Francisco and Shanghai. Meanwhile, with the $25-billion federal aid having expired on Sep 30 and a second round of stimulus not yet

MarketAxess Holdings Inc. MKTX reported total monthly trading volume of $461 billion for September 2020, which highlighted a whopping improvement of 161.7% year over year.

Humana Inc. HUM recently inked an in-network deal with Centura Health in Colorado Springs. Humana Medicare members will now have access to enhanced healthcare with this agreement, which will be effective Jan 1, 2021.The company’s Medicare Advantage health maintenance organizat

ImmunoGen, Inc. IMGN announced that the FDA has granted a Breakthrough Therapy designation to its novel CD123-targeted antibody-drug conjugate (ADC) IMGN632 for the treatment of patients with relapsed/refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and ag

SpringWorks Therapeutics, Inc. SWTX announced that it has entered into a clinical collaboration with pharma giant Pfizer PFE to evaluate its investigational gamma secretase inhibitor (GSI) nirogacestat in combination with the latter’s BCMA-targeted therapy PF-06863135 for the

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.